Update of Internal Medicine

Update in general internal medicine.

Update in general internal medicine.

The big news in women’s health in 2002 came from the Women’s Health Initiative (WHI) report, which found that combined hormone replacement therapy (HRT) (estrogen plus progestin) exposes postmenopausal women to more risk than benefit. Before this report, most observational studies showed that HRT decreased risk for heart disease by as much as 35%. In retrospect, however, many of these studies d...

Answers to Nephrology : Challenging Cases Update in Internal Medicine – 2016

1. A. The sodium-glucose transporter-2 (SGLT-2) inhibitors, empaglifloxin (Jardiance®), dapagliflozin (Farxiga®), and canagliflozin (Invokana®) inhibit proximal tubular glucose reabsorption resulting in renal glucosuria. These drugs can cause weight loss, natriuresis with volume depletion, hypotension, bacterial or fungal UTI, and ketoacidosis even in Type 2 diabetics. Ketoacidosis is more like...

Annals of Internal Medicine

Number 47 Recently we identified Citation C[as-sics TM from theleadlng journals ofmedi-tine. The first two essays in this series fo-cused on the New England Journa[ of Medicinel and The Lancet.2 For this essay, we've identified 101 papers from Annals of Internal Medicine using Science Citation Index " (.SCP) data from 1961 to 1982. Annak of Internal Medicine is published by the American College...

Annals of Internal Medicine

Background: Guidelines advocate changes in fatty acid consumption to promote cardiovascular health.